The new amphiphilic dinucleoside phosphate, 2'-deoxy-PaCa 2, the amphiphilic dimer was significantly more effec-5-fluorouridylyl-(3'~5')-2'-deoxy-5-fluoro-N4-octadecylcyti-tive than the parent monomeric 5FdU. The ICs0 of the dimer dine (4) was synthesized on a gram scale, using the was 10 pg/ml when applied as an aqueous solution and 12 phosphotriester method, starting from the cytostatic drug 2'-pg/ml when given as a liposome dispersion, whereas with deoxy-5-fluorouridine (5FdU) and 2'-deoxy-5-fluoro-N4-oc-5FdU the IC50 concentration was not reached within the contadecylcytidine (1 d). In in vitro clonogenic growth assays centration range used. using the human pancreatic adenocarcinoma cell line MIA SFdU is clinically used for the treatment of gastrointestinal tumors. The cytostatic activity of SFdU is considered to be primarily the result of the inhibition of DNA biosynthesis in the presence of 2'-deoxy-5-fluorouridine-5'-monophosphate (pSFdU)[ll. Cancer cells which lack the enzymes for the phosphorylation of SFdU to pSFdU are resistant against 5FdUW. However, because of its high polarity, p5FdU is not taken up by cells in its intact form, but rather as the dephosphorylated 5FdU [3]. Attempts to mask the phosphate group in such a way that the resulting prodrugs gain a facilitated entry into the cell and release pSFdU in the cytoplasm have generally proved to be unsuccessful. Important prodrugs containing masked p5FdU are the polar dinucleoside phosphates We have developed a new strategy of masking nucleoside phosphates by the synthesis of amphiphilic dinucleoside which is based on the condensation of a lipophilic nucleoside with a nucleoside of known therapeutic activity, via a natural phosphodiester linkage. In comparison to polar nucleotides, these amphiphilic dimers possess the advantage that they can be incorporated into liposomes, forming stable dispersions. The formulation of the prodrugs in liposomes can offer additional properties. This paper concerns the derivatization of SFdU into an amphiphilic dinucleoside phosphate, and the first results of the in vitro cytostatic activity of the amphiphilic dimer are reported.The amphiphilic dinucleoside phosphate 2'-deoxy-5-fluorouridylyl-(3'~5')-2'-deoxy-5-fluoro-N4-octadecylcytidine (4) was synthesized (Scheme 2 ) according to the phosphotriester starting from the hydroxyl compound 3'-O-acetyl-2'-deoxy-S-fluoro-N4-octadecylcytidine (10 and the protected 3'-phosphate compound, the barium salt of 2'-deoxy-5'-O-(4,4'-dimethoxy)trityl-5-fluorouridine-3'-(2-chlorophenyl)phosphate (3). The new lipophilic compound Id was synthesized in four steps in an analogous manner to N4-octadecyl-1 -~-~-arabinofuranosykytosine['~], starting from SFdU (Scheme 1). The condensation of the phosphate compound 3 with the hydroxyl compound If was performed using 2,4,6-triisopropylbenzenesulfonyl chloride (TPS) and N-methylimidazole as condensation agents. After chromatographing the reaction mixture on silica gel, the 2-chlorophenyl group was removed with tetrabutylammonium fluoride from...